Osteoprotegerin, Human, ELISA Kit

データシート

• 商品コード：RD194003200
• メーカー：BLM
• 包装：1kit
• 価格： ¥125,000
• 在庫：無(未発注)

マイリストに追加 マイリストに追加済

• No.： 1
• 文献情報：
  Abd El Dayem SM et al. Bone mineral density, bone turnover markers, lean mass, and fat mass in Egyptian children with congenital adrenal hyperplasia. Arch Med Sci 2010 Mar;6(1):104-10
  Abd El Dayem SM et al
  2010/01/01
  
• 備考：
  
• 参照：
  

• No.： 2
• 文献情報：
  Albu A et al. Bone metabolism regulators and arterial stiffness in postmenopausal women. Maturitas 2013 Oct;76(2):146-50
  Albu A et al
  2013/01/01
  
• 備考：
  
• 参照：
  

• No.： 3
• 文献情報：
  Boyapati A et al. Sarilumab plus methotrexate suppresses circulating biomarkers of bone resorption and synovial damage in patients with rheumatoid arthritis and inadequate response to methotrexate: a biomarker study of MOBILITY. Arthritis Res. Ther. 2016
  Boyapati A et al
  2016/01/01
  
• 備考：
  
• 参照：
  

• No.： 4
• 文献情報：
  Cao H et al. Serum sRANKL/OPG predict recurrence after radiofrequency catheter ablation of lone atrial fibrillation. Int. J. Cardiol. 2014 Jan;170(3):298-302
  Cao H et al
  2014/01/01
  
• 備考：
  
• 参照：
  

• No.： 5
• 文献情報：
  Cao H et al. Preoperative serum soluble receptor activator of nuclear factor-κB ligand and osteoprotegerin predict postoperative atrial fibrillation in patients undergoing cardiac valve surgery. Ann. Thorac. Surg. 2013 Sep;96(3):800-6
  Cao H et al
  2013/01/01
  
• 備考：
  
• 参照：
  

• No.： 6
• 文献情報：
  Chae SY et al. The Correlation of Serum Osteoprotegerin with Non-Traditional Cardiovascular Risk Factors and Arterial Stiffness in Patients with Pre-Dialysis Chronic Kidney Disease: Results from the KNOW-CKD Study. J. Korean Med. Sci. 2018 Dec;33(53):e322
  Chae SY et al
  2018/01/01
  
• 備考：
  
• 参照：
  

• No.： 7
• 文献情報：
  di Giuseppe R et al. Plasma osteoprotegerin, its correlates, and risk of heart failure: a prospective cohort study. Eur. J. Epidemiol. 2017 02;32(2):113-123
  di Giuseppe R et al
  2017/01/01
  
• 備考：
  
• 参照：
  

• No.： 8
• 文献情報：
  El-Shehaby A et al. Correlations of urinary biomarkers, TNF-like weak inducer of apoptosis (TWEAK), osteoprotegerin (OPG), monocyte chemoattractant protein-1 (MCP-1), and IL-8 with lupus nephritis. J. Clin. Immunol. 2011 Oct;31(5):848-56
  El-Shehaby A et al
  2011/01/01
  
• 備考：
  
• 参照：
  

• No.： 9
• 文献情報：
  Ford ML et al. FGF-23 and osteoprotegerin are independently associated with myocardial damage in chronic kidney disease stages 3 and 4. Another link between chronic kidney disease-mineral bone disorder and the heart. Nephrol. Dial. Transplant. 2012 Feb;27
  Ford ML et al
  2012/01/01
  
• 備考：
  
• 参照：
  

• No.： 10
• 文献情報：
  Friedmann A et al. Receptor activator of NF-kappaB ligand (RANKL) and CD 31 expressions in chronic periodontitis patients before and after surgery. Cent Eur J Immunol 2014;39(4):508-17
  Friedmann A et al
  2014/01/01
  
• 備考：
  
• 参照：
  

• No.： 11
• 文献情報：
  Gossiel F et al. The effect of bisphosphonate treatment on osteoclast precursor cells in postmenopausal osteoporosis: The TRIO study. Bone 2016 11;92:94-99
  Gossiel F et al
  2016/01/01
  
• 備考：
  
• 参照：
  

• No.： 12
• 文献情報：
  Kim CS et al. Association of Serum Osteoprotegerin Levels with Bone Loss in Chronic Kidney Disease: Insights from the KNOW-CKD Study. PLoS ONE 2016;11(11):e0166792
  Kim CS et al
  2016/01/01
  
• 備考：
  
• 参照：
  

• No.： 13
• 文献情報：
  Kolonko A et al. Cardiovascular Risk Factors and Markers of Atherosclerosis in Stable Kidney Transplant Recipients. Transplant. Proc. 2016 Jun;48(5):1543-50
  Kolonko A et al
  2016/01/01
  
• 備考：
  
• 参照：
  

• No.： 14
• 文献情報：
  Krela-Ka添mierczak I et al. Bone Metabolism and the c.-223C > T Polymorphism in the 5'UTR Region of the Osteoprotegerin Gene in Patients with Inflammatory Bowel Disease. Calcif. Tissue Int. 2016 12;99(6):616-624
  Krela-Ka添mierczak I et al
  2016/01/01
  
• 備考：
  
• 参照：
  

• No.： 15
• 文献情報：
  Motovska Z et al. Circulating osteoprotegerin and Dickkopf-1 changed significantly after surgical aortic valve replacement but remained without any significant differences after transcatheter aortic valve implantation. Int. J. Cardiol. 2012 Jul;158(2):300
  Motovska Z et al
  2012/01/01
  
• 備考：
  
• 参照：
  

• No.： 16
• 文献情報：
  Najar M et al. Breast cancer cells and bone marrow mesenchymal stromal cells: a regulated modulation of the breast tumor in the context of immune response. Inflamm. Res. 2017 Feb;66(2):129-139
  Najar M et al
  2017/01/01
  
• 備考：
  
• 参照：
  

• No.： 17
• 文献情報：
  Nakahara T et al. Fibroblast growth factor 23 inhibits osteoblastic gene expression and induces osteoprotegerin in vascular smooth muscle cells. Atherosclerosis 2016 10;253:102-110
  Nakahara T et al
  2016/01/01
  
• 備考：
  
• 参照：
  

• No.： 18
• 文献情報：
  Öztürk VÖ et al. Impact of implant-abutment connection on osteoimmunological and microbiological parameters in short implants: a randomized controlled clinical trial. Clin Oral Implants Res 2017 Sep;28(9):e111-e120
  Öztürk VÖ et al
  2017/01/01
  
• 備考：
  
• 参照：
  

• No.： 19
• 文献情報：
  Passeri E et al. Effects of 12-months treatment with zoledronate or teriparatide on intima-media thickness of carotid artery in women with postmenopausal osteoporosis: A pilot study. Int J Immunopathol Pharmacol 2019;33:2058738418822439
  Passeri E et al
  2019/01/01
  
• 備考：
  
• 参照：
  

• No.： 20
• 文献情報：
  Salah H et al. The clinical significance of OPG/sRANKL ratio in thalassemia patients suffering from osteopenia or osteoporosis in Egyptian patients. Immunol Invest 2010;39(8):820-32
  Salah H et al
  2010/01/01
  
• 備考：
  
• 参照：
  

• No.： 21
• 文献情報：
  Salama HM et al. The effects of L-thyroxin replacement therapy on bone minerals and body composition in hypothyroid children. Arch Med Sci 2010 Jun;6(3):407-13
  Salama HM et al
  2010/01/01
  
• 備考：
  
• 参照：
  

• No.： 22
• 文献情報：
  Silva HC et al. Higher prevalence of morphometric vertebral fractures in patients with recent coronary events independently of BMD measurements. Bone 2013 Feb;52(2):562-7
  Silva HC et al
  2013/01/01
  
• 備考：
  
• 参照：
  

• No.： 23
• 文献情報：
  Stavroulopoulos A et al. Evolution of coronary artery calcification in patients with chronic kidney disease Stages 3 and 4, with and without diabetes. Nephrol. Dial. Transplant. 2011 Aug;26(8):2582-9
  Stavroulopoulos A et al
  2011/01/01
  
• 備考：
  
• 参照：
  

• No.： 24
• 文献情報：
  Tousoulis D et al. Serum osteoprotegerin and osteopontin levels are associated with arterial stiffness and the presence and severity of coronary artery disease. Int J Cardiol 2013 Sep;167(5):1924-8
  Tousoulis D et al
  2013/01/01
  
• 備考：
  
• 参照：
  

• No.： 25
• 文献情報：
  テ奔den FO et al. Effect of bisphosphonate as an adjunct treatment for chronic periodontitis on gingival crevicuar fluid levels of nuclear factor-κB ligand (RANKL) and osteoprotegerin in postmenopausal osteoporosis. J Oral Sci 2017;59(1):147-155
  テ奔den FO et al
  2017/01/01
  
• 備考：
  
• 参照：
  

• No.： 26
• 文献情報：
  Vezzani G et al. Hyperbaric oxygen therapy modulates serum OPG/RANKL in femoral head necrosis patients. J Enzyme Inhib Med Chem 2017 Dec;32(1):707-711
  Vezzani G et al
  2017/01/01
  
• 備考：
  
• 参照：
  

• No.： 27
• 文献情報：
  Garcia Ferrer HR et al. Potential risk factors for reactive arthritis and persistence of symptoms at 2 years: a case-control study with longitudinal follow-up. Clin. Rheumatol. 2018 Feb;37(2):415-422
  Garcia Ferrer HR et al
  2018/01/01
  
• 備考：
  
• 参照：
  

• No.： 28
• 文献情報：
  Lee SM et al. Abdominal aortic calcification score among several vascular calcification scores of plain radiograph is the most reliable predictor of severe coronary artery calcification in dialysis patients. Ren Fail 2017 Nov;39(1):729-735
  Lee SM et al
  2017/01/01
  
• 備考：
  
• 参照：
  

• No.： 29
• 文献情報：
  Friedrich MJ et al. RANK-ligand and osteoprotegerin as biomarkers in the differentiation between periprosthetic joint infection and aseptic prosthesis loosening. World J Orthop 2017 Apr;8(4):342-349
  Friedrich MJ et al
  2017/01/01
  
• 備考：
  
• 参照：
  

• No.： 30
• 文献情報：
  Bruhn-Olszewska B et al. Prevalence of polymorphisms in OPG, RANKL and RANK as potential markers for Charcot arthropathy development. Sci Rep 2017 03;7(1):501
  Bruhn-Olszewska B et al
  2017/01/01
  
• 備考：
  
• 参照：